PRESS RELEASE published on 02/10/2026 at 18:00, 5 months 25 days ago THX Pharma et Biocodex annoncent un accord stratégique de licences dans trois maladies rares Biocodex acquiert les licences mondiales de Batten-1 et de TX01 pour le traitement de maladies rares en collaboration avec THX Pharma. Accord stratégique pour le développement et la commercialisation Maladies Rares Batten-1 TX01 THX Pharma Biocodex
BRIEF published on 01/27/2026 at 18:05, 6 months 11 days ago Theranexus Liquidity Contract Half-Year Review Liquidity Contract PORTZAMPARC Financial Report Theranexus THX Pharma Actions
BRIEF published on 01/27/2026 at 18:05, 6 months 11 days ago Bilan semestriel du contrat de liquidité de Theranexus Contrat De Liquidité PORTZAMPARC Bilan Financier Theranexus Actions THX Pharma
PRESS RELEASE published on 01/27/2026 at 18:00, 6 months 11 days ago BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ CONFIÉ À PORTZAMPARC THX Pharma publie le bilan semestriel de son contrat de liquidité confié à Portzamparc. Détails des titres et montants du compte de liquidité au 31/12/2025 Contrat De Liquidité Bilan Semestriel PORTZAMPARC Maladies Neurologiques Rares THX Pharma
BRIEF published on 01/20/2026 at 18:05, 6 months 18 days ago THX Pharma Reveals 2026 Financial Schedule Financial Calendar Neurological Diseases Market Communication 2026 Announcements THX Pharma
BRIEF published on 01/20/2026 at 18:05, 6 months 18 days ago THX Pharma dévoile son calendrier financier 2026 Euronext Paris Agenda Financier Biopharmaceutique 2026 THX Pharma
BRIEF published on 01/20/2026 at 18:05, 6 months 18 days ago THX Pharma unveils its 2026 financial calendar Euronext Paris Financial Agenda Biopharmaceutical 2026 THX Pharma
BRIEF published on 01/20/2026 at 18:05, 6 months 18 days ago THX Pharma dévoile son calendrier financier pour 2026 Calendrier Financier Maladies Neurologiques THX Pharma Annonces De 2026 Communication Marketing
PRESS RELEASE published on 01/20/2026 at 18:00, 6 months 18 days ago THX Pharma Announces its 2026 Financial Calendar THX Pharma (Theranexus) announces financial communication agenda for 2026, focusing on rare neurological diseases treatments. Company listed on Euronext Growth Paris Euronext Growth Paris Financial Communication Theranexus Neurological Diseases THX Pharma
PRESS RELEASE published on 01/20/2026 at 18:00, 6 months 18 days ago THX Pharma publie son agenda financier 2026 THX Pharma publie son agenda financier 2026, incluant les dates de communication financière et informations sur ses médicaments innovants. Retrouvez plus d'informations sur http://www.theranexus.com Communication Financière Agenda Financier Médicaments Neurologiques Rares THX Pharma
Published on 08/07/2026 at 23:15, 15 hours 18 minutes ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 15 hours 33 minutes ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 16 hours 3 minutes ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 16 hours 18 minutes ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/07/2026 at 23:21, 15 hours 12 minutes ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 19 hours 3 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 19 hours 18 minutes ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 20 hours 23 minutes ago Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:00, 20 hours 33 minutes ago E-PANGO: Composition du capital au 31 juillet 2026
Published on 08/07/2026 at 18:54, 19 hours 39 minutes ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 19 hours 39 minutes ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 19 hours 53 minutes ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 19 hours 53 minutes ago Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 20 hours 33 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026
